Literature DB >> 25303224

Redox signalling and cardioprotection: translatability and mechanism.

P Pagliaro1, C Penna.   

Abstract

The morbidity and mortality from coronary artery disease (CAD) remain significant worldwide. The treatment for acute myocardial infarction has improved over the past decades, including early reperfusion of culprit coronary arteries. Although it is mandatory to reperfuse the ischaemic territory as soon as possible, paradoxically this leads to additional myocardial injury, namely ischaemia/reperfusion (I/R) injury, in which redox stress plays a pivotal role and for which no effective therapy is currently available. In this review, we report evidence that the redox environment plays a pivotal role not only in I/R injury but also in cardioprotection. In fact, cardioprotective strategies, such as pre- and post-conditioning, result in a robust reduction in infarct size in animals and the role of redox signalling is of paramount importance in these conditioning strategies. Nitrosative signalling and cysteine redox modifications, such as S-nitrosation/S-nitrosylation, are also emerging as very important mechanisms in conditioning cardioprotection. The reasons for the switch from protective oxidative/nitrosative signalling to deleterious oxidative/nitrosative/nitrative stress are not fully understood. The complex regulation of this switch is, at least in part, responsible for the diminished or lack of cardioprotection induced by conditioning protocols observed in ageing animals and with co-morbidities as well as in humans. Therefore, it is important to understand at a mechanistic level the reasons for these differences before proposing a safe and useful transition of ischaemic or pharmacological conditioning. Indeed, more mechanistic novel therapeutic strategies are required to protect the heart from I/R injury and to improve clinical outcomes in patients with CAD.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25303224      PMCID: PMC4386976          DOI: 10.1111/bph.12975

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  255 in total

Review 1.  Free radicals and their involvement during long-term myocardial ischemia and reperfusion.

Authors:  J M Downey
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

Review 2.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 3.  Contribution of delayed intracellular pH recovery to ischemic postconditioning protection.

Authors:  Javier Inserte; Marisol Ruiz-Meana; Antonio Rodríguez-Sinovas; Ignasi Barba; David Garcia-Dorado
Journal:  Antioxid Redox Signal       Date:  2010-10-06       Impact factor: 8.401

4.  Intracoronary enalaprilat during angioplasty for acute myocardial infarction: alleviation of postischaemic neurohumoral and inflammatory stress?

Authors:  U Schaefer; T Kurz; H Bonnemeier; A Dendorfer; F Hartmann; H Schunkert; G Richardt
Journal:  J Intern Med       Date:  2007-02       Impact factor: 8.989

Review 5.  Membrane transport of hydrogen peroxide.

Authors:  Gerd P Bienert; Jan K Schjoerring; Thomas P Jahn
Journal:  Biochim Biophys Acta       Date:  2006-03-10

Review 6.  Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning.

Authors:  Péter Ferdinandy; Richard Schulz
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

7.  Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.

Authors:  Howard D Sesso; Julie E Buring; William G Christen; Tobias Kurth; Charlene Belanger; Jean MacFadyen; Vadim Bubes; JoAnn E Manson; Robert J Glynn; J Michael Gaziano
Journal:  JAMA       Date:  2008-11-09       Impact factor: 56.272

Review 8.  Biological nitric oxide signalling: chemistry and terminology.

Authors:  Tassiele A Heinrich; Roberto S da Silva; Katrina M Miranda; Christopher H Switzer; David A Wink; Jon M Fukuto
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

Review 9.  Oxidative stress-elicited myocardial apoptosis during reperfusion.

Authors:  Zhi-Qing Zhao
Journal:  Curr Opin Pharmacol       Date:  2004-04       Impact factor: 5.547

10.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

View more
  31 in total

Review 1.  Effect of hyperglycaemia and diabetes on acute myocardial ischaemia-reperfusion injury and cardioprotection by ischaemic conditioning protocols.

Authors:  Claudia Penna; Ioanna Andreadou; Manuela Aragno; Christophe Beauloye; Luc Bertrand; Antigone Lazou; Ines Falcão-Pires; Robert Bell; Coert J Zuurbier; Pasquale Pagliaro; Derek J Hausenloy
Journal:  Br J Pharmacol       Date:  2020-03-09       Impact factor: 8.739

2.  'Conditioning the heart' - lessons we have learned from the past and future perspectives for new and old conditioning 'drugs'.

Authors:  Nina C Weber
Journal:  Br J Pharmacol       Date:  2015-04       Impact factor: 8.739

3.  Mitochondrial phosphatase PGAM5 regulates Keap1-mediated Bcl-xL degradation and controls cardiomyocyte apoptosis driven by myocardial ischemia/reperfusion injury.

Authors:  Chen Yang; Xiaojuan Liu; Fangfang Yang; Weixun Zhang; Zihao Chen; Daliang Yan; Qingsheng You; Xiang Wu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-11-04       Impact factor: 2.416

Review 4.  From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview.

Authors:  Carlo Gabriele Tocchetti; Christian Cadeddu; Daniela Di Lisi; Saveria Femminò; Rosalinda Madonna; Donato Mele; Ines Monte; Giuseppina Novo; Claudia Penna; Alessia Pepe; Paolo Spallarossa; Gilda Varricchi; Concetta Zito; Pasquale Pagliaro; Giuseppe Mercuro
Journal:  Antioxid Redox Signal       Date:  2017-05-15       Impact factor: 8.401

Review 5.  Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection.

Authors:  Marco Bruno Morelli; Chiara Bongiovanni; Silvia Da Pra; Carmen Miano; Francesca Sacchi; Mattia Lauriola; Gabriele D'Uva
Journal:  Front Cardiovasc Med       Date:  2022-04-15

6.  Real-Time Fluorescence Measurements of ROS and [Ca2+] in Ischemic / Reperfused Rat Hearts: Detectable Increases Occur only after Mitochondrial Pore Opening and Are Attenuated by Ischemic Preconditioning.

Authors:  Tatyana Andrienko; Philippe Pasdois; Andreas Rossbach; Andrew P Halestrap
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

Review 7.  A Role for Photobiomodulation in the Prevention of Myocardial Ischemic Reperfusion Injury: A Systematic Review and Potential Molecular Mechanisms.

Authors:  Ann Liebert; Andrew Krause; Neil Goonetilleke; Brian Bicknell; Hosen Kiat
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

8.  Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects.

Authors:  Ioanna Andreadou; Panagiotis Efentakis; Evangelos Balafas; Gabriele Togliatto; Constantinos H Davos; Aimilia Varela; Constantinos A Dimitriou; Panagiota-Efstathia Nikolaou; Eirini Maratou; Vaia Lambadiari; Ignatios Ikonomidis; Nikolaos Kostomitsopoulos; Maria F Brizzi; George Dimitriadis; Efstathios K Iliodromitis
Journal:  Front Physiol       Date:  2017-12-19       Impact factor: 4.566

Review 9.  Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective.

Authors:  Gilda Varricchi; Pietro Ameri; Christian Cadeddu; Alessandra Ghigo; Rosalinda Madonna; Giancarlo Marone; Valentina Mercurio; Ines Monte; Giuseppina Novo; Paolo Parrella; Flora Pirozzi; Antonio Pecoraro; Paolo Spallarossa; Concetta Zito; Giuseppe Mercuro; Pasquale Pagliaro; Carlo G Tocchetti
Journal:  Front Physiol       Date:  2018-03-07       Impact factor: 4.566

Review 10.  The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development.

Authors:  Jonathan Hullmann; Christopher J Traynham; Ryan C Coleman; Walter J Koch
Journal:  Pharmacol Res       Date:  2016-05-12       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.